Desouza, N., Soutter, W., Rustin, G., Mahon, M., Jones, B., Dina, R., & Mclndoe, G. (2004). Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: Monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome. British Journal of Cancer, 90(12), 2326. https://doi.org/10.1038/sj.bjc.6601870
Chicago Style (17th ed.) CitationDesouza, Nm, Wp Soutter, G. Rustin, Mm Mahon, B. Jones, R. Dina, and Ga Mclndoe. "Use of Neoadjuvant Chemotherapy Prior to Radical Hysterectomy in Cervical Cancer: Monitoring Tumour Shrinkage and Molecular Profile on Magnetic Resonance and Assessment of 3-year Outcome." British Journal of Cancer 90, no. 12 (2004): 2326. https://doi.org/10.1038/sj.bjc.6601870.
MLA (9th ed.) CitationDesouza, Nm, et al. "Use of Neoadjuvant Chemotherapy Prior to Radical Hysterectomy in Cervical Cancer: Monitoring Tumour Shrinkage and Molecular Profile on Magnetic Resonance and Assessment of 3-year Outcome." British Journal of Cancer, vol. 90, no. 12, 2004, p. 2326, https://doi.org/10.1038/sj.bjc.6601870.